Injections intravitréennes dans l’œil d’ovins

Overview

This article presents a protocol for performing intravitreal injections in the sheep eye, which serves as a model for human ocular treatments. The method aims to deliver viral-mediated gene therapy to the retina, specifically targeting retinal degeneration.

Key Study Components

Area of Science

• Gene therapy
• Ophthalmology
• Animal models

Background

• Intravitreal injections are less invasive than other ocular injection methods.
• Sheep are used as a model due to similarities with the human eye.
• The study addresses retinal degeneration caused by neuronal ceroid lipofuscinoses.
• Gene therapy products can be effectively delivered using this method.

Purpose of Study

• To demonstrate a protocol for intravitreal injections in sheep.
• To explore the efficacy of gene therapy for retinal conditions.
• To provide a less invasive alternative for ocular treatments.

Methods Used

• Sheep are anesthetized prior to the procedure.
• The eye is disinfected using a povidone iodine solution.
• A sterile surgical drape is positioned over the eye.
• Intravitreal injections are performed to deliver the therapeutic agents.

Main Results

• The protocol successfully delivers gene therapy to the retina.
• Intravitreal injections show potential for treating retinal degeneration.
• The method is demonstrated to be effective in a sheep model.
• Results indicate a less invasive approach to ocular therapy.

Conclusions

• Intravitreal injections are a viable method for gene therapy delivery.
• This approach can be adapted for human applications.
• Further research is warranted to explore long-term effects.

Frequently Asked Questions